Parkkila S - Search Results

1

Activation Studies of the β-Carbonic Anhydrase from the Pathogenic Protozoan Entamoeba histolytica with Amino Acids and Amines.

Bua S, Haapanen S, Kuuslahti M, Parkkila S, Supuran CT. Bua S, et al. Among authors: parkkila s. Metabolites. 2019 Feb 1;9(2):26. doi: 10.3390/metabo9020026. Metabolites. 2019. PMID: 30717275 Free PMC article.

2

Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family.

Lehtonen J, Shen B, Vihinen M, Casini A, Scozzafava A, Supuran CT, Parkkila AK, Saarnio J, Kivelä AJ, Waheed A, Sly WS, Parkkila S. Lehtonen J, et al. Among authors: parkkila s, parkkila ak. J Biol Chem. 2004 Jan 23;279(4):2719-27. doi: 10.1074/jbc.M308984200. Epub 2003 Nov 4. J Biol Chem. 2004. PMID: 14600151 Free article.

3

Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.

Lehtonen JM, Parkkila S, Vullo D, Casini A, Scozzafava A, Supuran CT. Lehtonen JM, et al. Among authors: parkkila s. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3757-62. doi: 10.1016/j.bmcl.2004.04.106. Bioorg Med Chem Lett. 2004. PMID: 15203157

4

Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions.

Innocenti A, Lehtonen JM, Parkkila S, Scozzafava A, Supuran CT. Innocenti A, et al. Among authors: parkkila s. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9. doi: 10.1016/j.bmcl.2004.07.086. Bioorg Med Chem Lett. 2004. PMID: 15454240

5

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.

Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Pastorekova S, et al. Among authors: parkkila s. J Enzyme Inhib Med Chem. 2004 Jun;19(3):199-229. doi: 10.1080/14756360410001689540. J Enzyme Inhib Med Chem. 2004. PMID: 15499993 Review.

6

Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines.

Parkkila S, Vullo D, Puccetti L, Parkkila AK, Scozzafava A, Supuran CT. Parkkila S, et al. Among authors: parkkila ak. Bioorg Med Chem Lett. 2006 Aug 1;16(15):3955-9. doi: 10.1016/j.bmcl.2006.05.023. Epub 2006 May 30. Bioorg Med Chem Lett. 2006. PMID: 16730978

7

Membrane-bound carbonic anhydrases in osteoclasts.

Riihonen R, Supuran CT, Parkkila S, Pastorekova S, Väänänen HK, Laitala-Leinonen T. Riihonen R, et al. Among authors: parkkila s. Bone. 2007 Apr;40(4):1021-31. doi: 10.1016/j.bone.2006.11.028. Epub 2006 Dec 22. Bone. 2007. PMID: 17291844

8

Characterization and inhibition of the recently discovered carbonic anhydrase isoforms CA XIII, XIV and XV.

Hilvo M, Supuran CT, Parkkila S. Hilvo M, et al. Among authors: parkkila s. Curr Top Med Chem. 2007;7(9):893-9. doi: 10.2174/156802607780636672. Curr Top Med Chem. 2007. PMID: 17504134 Review.

9

Carbonic anhydrase inhibitors: the very weak inhibitors dithiothreitol, beta-mercaptoethanol, tris(carboxyethyl)phosphine and threitol interfere with the binding of sulfonamides to isozymes II and IX.

Innocenti A, Hilvo M, Scozzafava A, Lindfors M, Nordlund HR, Kulomaa MS, Parkkila S, Supuran CT. Innocenti A, et al. Among authors: parkkila s. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1898-903. doi: 10.1016/j.bmcl.2008.02.008. Epub 2008 Feb 9. Bioorg Med Chem Lett. 2008. PMID: 18295485

10

Recent advances in research on the most novel carbonic anhydrases, CA XIII and XV.

Hilvo M, Innocenti A, Monti SM, De Simone G, Supuran CT, Parkkila S. Hilvo M, et al. Among authors: parkkila s. Curr Pharm Des. 2008;14(7):672-8. doi: 10.2174/138161208783877811. Curr Pharm Des. 2008. PMID: 18336313 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page